Vaxxinity OverviewVaxxinity EBIT
EBIT (Earnings Before Interest and Taxes) analysis for VAXX.
Quarterly EBIT
-$11.65M
↑ 44.05% YoY
As of Dec 31, 2023
Annual EBIT (TTM)
-$57.24M
↑ 24.66% YoY
Trailing 12 months ending Dec 31, 2023
Vaxxinity OverviewEBIT (Earnings Before Interest and Taxes) analysis for VAXX.
As of Dec 31, 2023
Trailing 12 months ending Dec 31, 2023